EAGeR aims to recruit 1600 women aged 18-40 who have had one or two miscarriages in the past and who are actively trying to conceive. The study is conducted at three clinical sites: The University of Utah in Salt Lake City, Utah, the University at Buffalo, in Buffalo, New York and Moses Taylor Hospital, Scranton Pennsylvania. Participants are randomly assigned to receive either low-dose aspirin (LDA) or placebo and all receive folic acid. Follow-up continues for up to six menstrual cycles (about six months) if not becoming pregnant or until end of pregnancy. The main study outcome is live birth but all phases of reproduction and gestation will be assessed.
EAGeR was launched in June 2007 and will continue for five years.
The data coordinating center for EAGeR is at the University of Haifa, Haifa, Israel. If you have any questions about the website please email us at haifa-dcc@hevra.haifa.ac.il
EAGeR is supported by the NICHD.
Privacy and confidentiality
Privacy of your personal health information is very important to the study staff. Information about all study participants will be treated in strict confidence to the extent provided by law. Participants will be assigned a study identification number and no names will ever be used in ANY report resulting from this study.
All information gathered from participants will be done in a private area by experienced research staff. Personal information will not be shared with those not directly involved in the study. Personal information that has no relation to the study will not be shared with anyone.
Participants’ personal information, test results and other data will be kept confidential throughout the trial and stored in secured data archives. Personal information will be kept in a locked safe with limited access to specific study staff. Personal information is never released without prior permission from participants.
